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ABSTRACT Fungi are known to utilize transcriptional regulation of genes that encode
efflux transporters to detoxify xenobiotics; however, to date it is unknown how fungi
transcriptionally regulate and coordinate different phases of detoxification system (phase
I, modification; phase II, conjugation; and phase III, secretion). Here we present evidence
of an evolutionary convergence between the fungal and mammalian lineages, whereby
xenobiotic detoxification genes (phase I coding for cytochrome P450 monooxygenases
[CYP450s] and phase III coding for ATP-binding cassette [ABC] efflux transporters) are
transcriptionally regulated by structurally unrelated proteins. Following next-generation
RNA sequencing (RNA-seq) analyses of a filamentous fungus, Sclerotinia homoeocarpa,
the causal agent of dollar spot on turfgrasses, a multidrug resistant (MDR) field strain
was found to overexpress phase I and III genes, coding for CYP450s and ABC transport-
ers for xenobiotic detoxification. Furthermore, there was confirmation of a gain-of-
function mutation of the fungus-specific transcription factor S. homoeocarpa XDR1
(ShXDR1), which is responsible for constitutive and induced overexpression of the phase
I and III genes, resulting in resistance to multiple classes of fungicidal chemicals. This
fungal pathogen detoxifies xenobiotics through coordinated transcriptional control of
CYP450s, biotransforming xenobiotics with different substrate specificities and ABC
transporters, excreting a broad spectrum of xenobiotics or biotransformed metabolites.
A Botrytis cinerea strain harboring the mutated ShXDR1 showed increased expression of
phase I (BcCYP65) and III (BcatrD) genes, resulting in resistance to fungicides. This indi-
cates the regulatory system is conserved in filamentous fungi. This molecular genetic
mechanism for xenobiotic detoxification in fungi holds potential for facilitating discovery
of new antifungal drugs and further studies of convergent and divergent evolution of
xenobiotic detoxification in eukaryote lineages.
IMPORTANCE Emerging multidrug resistance (MDR) in pathogenic filamentous
fungi is a significant threat to human health and agricultural production. Under-
standing mechanisms of MDR is essential to combating fungal pathogens; however,
there is still limited information on MDR mechanisms conferred by xenobiotic detox-
ification. Here, we report for the first time that overexpression of phase I drug-
metabolizing monooxygenases (cytochrome P450s) and phase III ATP-binding
cassette efflux transporters is regulated by a gain-of-function mutation in the
fungus-specific transcription factor in the MDR strains of the filamentous plant-
pathogenic fungus Sclerotinia homoeocarpa. This study establishes a novel molecular
mechanism of MDR through the xenobiotic detoxification pathway in filamentous
fungi, which may facilitate the discovery of new antifungal drugs to control patho-
genic fungi.
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All organisms are constantly exposed to xenobiotics, such as toxic compounds, anddefend against these compounds through the coordinated action of metabolizing
enzymes and efflux transporter proteins. In mammals and insects, xenobiotic-induced
transcriptional regulation of the enzymes and transporters has been established (1, 2).
Multiple nuclear receptors have been identified in mammalian systems that contribute
to this regulatory response. For example, the nuclear receptor pregnane X receptor
(PXR), together with retinoid X receptor (RXR), directly binds structurally unrelated
xenobiotics and upregulates transcription of metabolizing enzymes and efflux trans-
porters (3). These include phase I metabolizing enzymes (cytochrome P450s, cyto-
chrome P proteins [CYPs], and monooxygenases) that catalyze xenobiotics and endo-
biotics mainly through hydroxylation/oxidation reactions (4, 5), phase II conjugating
enzymes (UDP-glucuronosyltransferase, sulfotransferase, and glutathione S-transferase)
that add polar molecules onto compounds, producing water-soluble, nontoxic metab-
olites (2, 6), and the phase III secretion system, consisting of ATP-binding cassette (ABC)
and other transmembrane transporters that actively export parent and/or metabolized
compounds across the cytoplasmic membrane (7). Unlike the detailed studies in
mammalian systems, the coordinated transcriptional regulation of the three-phase
system of these xenobiotic detoxification genes in fungi has not been characterized.
Most studies of xenobiotic detoxification in fungi have focused on antifungal drugs
(fungicides) and efflux activities by ABC or major facilitator superfamily (MFS) trans-
porters. The expression of efflux transporters is mainly regulated by fungal zinc-cluster
transcription factors (TFs [Zn2Cys6]) (3). Interestingly, Zn2Cys6 TF Pdr1 orthologs from
the model fungus Saccharomyces cerevisiae and human opportunistic pathogenic
fungus Candida glabrata were suggested to represent functional analogues of PXR
because of the similarities of the xenobiotic signaling by binding chemically diverse
xenobiotics and activating the expression of efflux transporters. Although protein
sequences and structural folds of PDR1 orthologs and PXR are clearly distinct, they
share general architectural similarities, such as DNA binding domains (DBDs) containing
cysteines, large ligand binding domains, and short activation domains. Therefore, it is
reasonable to propose that emergence of nuclear receptor-like ligand-dependent gene
regulatory mechanisms occurred early during eukaryotic evolution, but it has not been
determined whether PDR1 orthologs and PXR evolved convergently or divergently (8).
Furthermore, in contrast to PXR regulatory mechanisms, Pdr1 orthologs activate ex-
pression of phase III efflux transporters only, but not phase I and II metabolizing
enzymes during metabolism of xenobiotics.
The emergence of multidrug resistance (MDR) in both pathogenic fungi and human
cancers has had a profound impact on human health. The human PXR has been
suggested to play an important role in MDR in cancers because of the upregulation of
its expression in different cancer cells, its great flexibility in recognizing structurally
diverse compounds, and its role as a master regulator of a three-phase detoxification
system (9). However, the direct function of upregulation or mutation(s) in PXR to MDR
in human cancers in vivo has not been understood (8). In human-pathogenic yeasts,
molecular mechanisms of MDR have been characterized through functional studies of
activating mutation(s) in Zn2Cys6 transcription factors (PDR1 in C. glabrata or Tac1 in C.
albicans), which confer upregulation of efflux transporters resulting in MDR (10–12). The
recent studies of gene activation by PDR1 and the Gal11p/MED15 mediator led to the
finding of a compound (iKIX1) that disrupts the interaction between PDR1 and medi-
ator and inhibits MDR in C. glabrata strains (13). MDR in filamentous human- and
plant-pathogenic fungi is a growing issue to threaten human health and agricultural
production (14), but there is a lack of information on MDR mechanisms conferred by
the xenobiotic detoxification system for filamentous pathogenic fungi due to limited
evolutionary conservation of the subfamily of transcription factors involved in MDR
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regulation between Saccharomycotina (ascomycete yeasts) and Pezizomycotina (fila-
mentous ascomycete fungi).
Sclerotinia homoeocarpa is a filamentous ascomycete fungus and the causal agent of
dollar spot on turfgrasses. Due to repeated application of multiple fungicides, S. ho-
moeocarpa populations have developed resistance to benzimidazole, dicarboximide,
demethylation inhibitor (DMI), and succinate dehydrogenase inhibitor (SDHI) fungi-
cides (15–18). Recently, the emergence of MDR populations has been reported in
S. homoeocarpa (19). In this study, next-generation RNA sequencing (RNA-seq) analyses
of an MDR field strain of S. homoeocarpa revealed enrichment of CYPs and ABC efflux
transporters associated with phases I and III of a xenobiotic detoxification system,
respectively. We show here that detoxification of different classes of chemicals in
S. homoeocarpa occurs through multiple CYPs and ABC transporters, which are coor-
dinately regulated by a putative xenobiotic detoxification regulator (ShXDR1). Further-
more, our results demonstrate a novel gain-of-function dominant mutation (M853T) in
S. homoeocarpa XDR1 (ShXDR1M853T), identified from the MDR field strain, is responsi-
ble for overexpression of both phase I and III genes, leading to MDR. The mechanistic
similarity in ways of transcriptionally regulating metabolizing enzymes and efflux
transporters for xenobiotic detoxification in fungi and animals suggests new evolution-
ary insight into xenobiotic detoxification in eukaryotes.
RESULTS
Differential gene expression between S. homoeocarpa drug-sensitive and MDR
field strains. To determine the MDR mechanism in S. homoeocarpa, in vitro sensitivity
tests of five MDR field strains and five drug-sensitive field strains to different classes of
fungicides (19) and the plant growth regulator (gibberellin biosynthesis inhibitor) were
conducted in this study. The group of MDR strains exhibited significant resistance to
propiconazole, iprodione, boscalid, and flurprimidol (P 0.001) compared to the group
of drug-sensitive strains (Fig. 1A). Samples from one of the MDR strains, HRI11, and one
FIG 1 RNA-seq of the drug-sensitive strain HRS10 and multidrug-resistant (MDR) strain HRI11 in the absence and presence of the DMI fungicide
propiconazole. (A) In vitro sensitivity of drug-sensitive and MDR strains to fungicides and plant growth regulator. Mean values from five MDR
strains and five sensitive strains are shown. EC50 values for propiconazole, iprodione, and flurprimidol and EC95 (†) values for boscalid are shown
for sensitive strains. The fold values of EC50 and EC95 values for sensitive strains are shown for MDR strains. Significant differences from mean
values of sensitive strains are indicated by asterisks: *, P  0.001. (B) Expression patterns for 208 genes constitutively overexpressed (log2 fold
change of 1.5 and P  0.05) in strain HRI11, compared to the genes in strain HRS10, before and after treatment with propiconazole. Red
indicates higher relative expression, and green indicates lower relative expression. Three major groups of genes, A (n  13), B (n  57), and C
(n 138), were clustered based on the analysis of hierarchical clustering of gene expression patterns. (C) FPKM of 13 genes from group A in strains
HRS10 and HRI11 before and after exposure to propiconazole.
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of the drug-sensitive strains, HRS10, before and after exposure to propiconazole (0.1 g
ml1) for 1 h were used for next-generation RNA sequencing (RNA-seq) to profile
genome-wide patterns of differential gene expression between these two strains.
RNA-seq analysis identified a total of 28,914 transcripts, corresponding to 12,008
total genes, under the four conditions for both strains. As described previously by
Hulvey et al. (20), the strains HRS10 and HRI11 are putative clones. HRI11’s genome was
chosen to be the reference because its draft genome is more fully complete. To verify
the similarity between the genomes of the two strains, the transcripts were aligned to
the whole genomes by BLASTN using an E value set to 0.001. Among the 28,914
transcripts, 28,901 transcripts mapped to HRI11’s genome, and 28,640 mapped to
HRS10’s genome. Volcano plots of RNA-seq data indicated that among the 9,499 genes
used in the analysis, 55, 7, 94, and 116 genes were significantly downregulated and 59,
11, 208, and 152 genes were significantly upregulated in HRS10 versus HRS10 plus
propiconazole, HRI11 versus HRI11 plus propiconazole, HRS10 versus HRI11, and HRS10
plus propiconazole versus HRI11 plus propiconazole, respectively (see Fig. S1 in the
supplemental material).
Two hundred eight genes in the MDR strain showed significantly higher expression
(log2 fold change of 1.5 at P  0.05) than the genes in the sensitive strain. The 208
genes were clustered into three major groups by the analysis of hierarchical clustering
of gene expression patterns (Fig. 1B). Group A consisted of 13 genes that showed
constitutive overexpression and propiconazole-induced expression in the MDR strain.
This group includes three genes coding for cytochrome P450s (CYP450s) and two genes
coding for ABC transporters (ShPDR1 and ShatrD) previously confirmed for indirect or
direct involvement in fungicide resistance (19, 20). These CYP450s and ABC transporters
belong to phases I and III in the xenobiotic detoxification pathway, respectively. The
group also includes one lysophospholipase (phospholipase B1) gene, one cellulose-
binding protein gene, one carbohydrate-binding protein gene, one emopamil-binding
protein (EBP) gene, and four hypothetical protein genes (Fig. 1C). We found that the
majority of group A genes encode proteins involved in oxidation reduction process
(GO:0055114) and transmembrane transport (GO:0055085). Group B consisted of 57
genes that were constitutively overexpressed in the MDR strain but showed no
difference or less reduction of expression in response to propiconazole compared to
the genes in the sensitive strain. This group includes one dioxygenase gene and one
MFS transporter gene that are related to xenobiotic detoxification. The majority of
group B genes are related to oxidation reduction process and proteolysis (GO:0006508).
Group C consisted of 138 genes that displayed constitutive overexpression and down-
regulated expression after treatment of propiconazole in the MDR strain. This group
includes xenobiotic detoxification-related genes that include one cytochrome 450
gene, one flavin-binding monooxygenase gene, one glutathione S-transferase gene,
and three MFS transporter genes. Many genes in this group were found to be
associated with single organism cellular process (GO:0044763), oxidation reduction
process, and cellular nitrogen compound biosynthetic process (GO:0044271).
Xenobiotic detoxification through phase I cytochrome P450s and phase III ABC
transporters. To validate whether overexpression of genes coding for three phase I
enzymes (CYP561, CYP65, and CYP68) and two phase III transporters (ShPDR1 and
ShatrD) selected from group A is responsible for xenobiotic detoxification and MDR
phenotypes, expression of these phase I and III genes was quantified at different
propiconazole exposure times and in response to different classes of fungicides and
one plant growth regulator. In addition, the overexpression mutants of phase I and III
genes from a drug-sensitive strain HRS10 were generated. The expression of CYP561,
CYP65, CYP68, ShPDR1, and ShatrD was induced after treatment of propiconazole
between 20 and 40 min in the sensitive strain, HRS10 (Fig. 2A), whose transcriptional
response was rapid and transient. These five genes were also constitutively overex-
pressed in the MDR strain and induced by propiconazole, boscalid, flurprimidol, and
iprodione in both sensitive and MDR strains (Fig. 2B).
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Mutants with CYP561, CYP65, and CYP68 overexpressed exhibited significantly
increased levels of resistance to propiconazole and flurprimidol compared with strain
HRS10. Mutants with CYP65 and CYP68 overexpressed showed significantly reduced
sensitivity to boscalid, and only the mutant with CYP561 overexpressed displayed
resistance to iprodione (Fig. 3A). In addition, overexpression of CYP561, CYP65, and
CYP68 led to increases in the biotransformation rate of propiconazole. Especially, the
biotransformation rate constants of propiconazole for 24 h in HRS10 with CYP561,
CYP65, and CYP68 overexpressed were 2.6-, 3.1-, and 3.8-fold higher than those of
propiconazole in HRS10, respectively (Fig. 3B). The biotransformation activities by three
CYP450s might be due to catalyzation of propiconazole to produce hydroxylated (-OH)
metabolites (21). Mutants with phase III transporter ShatrD and ShPDR1 overexpressed
exhibited reduced sensitivities to chemically different fungicides and the plant growth
regulator compared with strain HRS10 (Fig. 4A). Heterologous expression of ShPDR1 or
ShatrD in a drug-hypersensitive yeast mutant (AD12345678 [designated AD1–8 here])
further confirmed that these transporters are involved in MDR (Fig. 4B). Therefore,
overexpression of three CYP450s and two ABC transporters contributes to multidrug
resistance in the MDR strain by the phase I and III detoxification pathway.
A xenobiotic detoxification regulator, ShXDR1, coordinately regulates phase I
and III genes, and a gain-of-function mutation in ShXDR1 leads to MDR. To find the
genetic factor leading to overexpression of three CYP450s and two ABC transporters in
the MDR strain, we first compared the upstream regions of CYP561 (1,314 bp), CYP65
(843 bp), CYP68 (645 bp), ShPDR1 (1,566 bp) and ShatrD (1,654 bp) between strains
HRS10 and HRI11 using genome sequences generated by Green et al. (22). The 459-bp
upstream region of ShPDR1 and 1,000-bp upstream region of ShatrD from strains HRS10
and HRI11 were reported in previous publications (19, 20). The comparison of these five
genes’ upstream regions revealed that the regions of HRS10 and HRI11 are identical.
Since the differential expressions of five genes between the strains HRS10 and HRI11
showed a similar pattern (Fig. 2A and B), we speculated that all of them might be
simultaneously regulated and the MDR phenotype might be caused by a mutation(s) in
one of the members of the fungus-specific Zn2Cys6 family, which have been known to
be the regulator of ABC transporters in other fungal systems (3, 14, 23). We conducted
FIG 2 Expression patterns of phase I CYP450s and phase III transporters in response to fungicides and plant growth regulator. (A) Relative
expression (RE) of phase I genes (CYP561, CYP65, and CYP68) and phase III genes (ShPDR1 and ShatrD) before and after exposure to propiconazole
(1 g ml1) for 10, 20, 40, and 60 min in strain HRS10. (B) RE of phase I and III genes before and after exposure to propiconazole (1 g ml1),
boscalid (100 g ml1), flurprimidol (10 g ml1), and iprodione (10 g ml1) for 40 min in strains HRS10 and HRI11.
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a probability variant detection analysis between sequences of 78 putative Zn2Cys6
transcription factors from strains HRS10 and HRI11 and found that one of the transcripts
(TCONS_00003992) has an amino acid substitution in the MDR strain HRI11 (Fig. 5A).
The substitution is methionine (ATG) to threonine (ACG) at codon 853 (M853T) in
xenobiotic detoxification regulator 1, ShXDR1, in strain HRI11. Sequencing of the
transcription factor (ShXDR1) in additional five drug-sensitive and five MDR strains
collected from the same site where HRI11 and HRS10 originated indicated that all five
MDR strains contained this mutation, which was not found in the sensitive strains.
To confirm the ShXDR1 gene encodes the transcription factor responsible for
overexpression of five phase I and III genes, leading to multidrug resistance in MDR
strain HRI11, we generated the ShXDR1 deletion mutants using a split marker approach
and an approach with a CRISPR-Cas9 system, ShXDR1 knockdown mutants, and
ShXDR1M853 mutants from strain HRI11. ShXDR1 deletion and knockdown and the
replacement of ShXDR1T853 with ShXDR1M853 in strain HRI11 led to increased sensitivity
to propiconazole, iprodione, boscalid, and flurprimidol (Fig. 5B; see Fig. S2A in the
supplemental material) and decreased constitutive expression of five detoxification
genes (Fig. 5C; Fig. S2B). Also, the expression of five genes was not induced by
propiconazole in the ShXDR1 deletion mutant but induced by propiconazole in the
HRI11(ShXDR1M853) mutant that showed a similar expression pattern to the sensitive
strain HRS10 (Fig. 5C). In this study, an efficient target (ShXDR1) deletion method was
developed using the split marker method with a CRISPR-Cas9 system in S. homoeo-
carpa. A propiconazole-sensitive mutant was not generated from protoplasts of HRI11
using polyethylene glycol (PEG)-mediated transformation with donor vector DNA only
(Topo-ΔShXDR1), but the addition of two vectors containing Cas9 endonuclease and
CRISPR RNA:transactivating CRISPR RNA (crRNA:tracrRNA) chimeric guide RNA with
FIG 3 Phase I CYP450s are involved in xenobiotic detoxification and multidrug resistance. (A) Sensitivity
of strain HRS10 and mutants overexpressing CYP561, CYP65, and CYP68 to fungicides and plant growth
regulator. (B) Propiconazole biotransformation rate of strain HRS10 and mutants overexpressing CYP561,
CYP65, and CYP68 by HPLC analysis.
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target ShXDR1 sequences, respectively, contributed to successful ShXDR1 deletions.
Furthermore, the method with split marker DNA plus the CRISPR-Cas9 system displayed
high success rates of ShXDR1 deletion mutants from HRI11, showing increased sensi-
tivity to propiconazole and decreased expression of ShatrD (see Fig. S3 in the supple-
mental material).
Finally, to test whether the M853T mutation is sufficient for the generation of the
MDR phenotype in strain HRI11 and to determine whether this gain-of-function mu-
tation is dominant or recessive, we transformed a plasmid with an upstream segment
(1,581 bp) and the full length of ShXDR1T853 into strain HRS10. The mutant
HRS10(ShXDR1T853) exhibited multidrug resistance to different fungicides and the
plant growth regulator, similar to strain HRI11 (Fig. 6A), and showed constitutive
upregulation of the five detoxification genes (Fig. 6B). Taken together, these results
indicated that the MDR phenotype in the strain HRI11 was caused by a dominant
gain-of-function mutation, M853T, in ShXDR1.
Interaction of ShXDR1 on promoter regions of phase I and III genes and
additional ShXDR1 target gene regulon. To identify the ShXDR1 binding site in the
promoter region of ShPDR1, 5= deletions in each promoter were cloned in frame with
the yellow fluorescent protein (YFP) reporter gene in pYHN3 (24), and the resulting
constructs were transformed into strain HRI11. A 2.3-fold increase in relative expression
of YFP was observed when the mutant HRI11-1289PDR1, containing the 1,289-bp
FIG 4 Phase III transporters are involved in xenobiotic detoxification and multidrug resistance. (A) Sensitivity of strain HRS10 and mutants overexpressing
ShPDR1 and ShatrD to fungicides and plant growth regulator. (B) Heterologous expression of ABC transporter ShPDR1 or ShatrD in a drug-hypersensitive yeast
mutant (AD1–8). Sensitivity tests of the yeast strains were performed on Bacto yeast nitrogen base (YNB) agar medium lacking uracil, containing 2% galactose
and amended with different classes of fungicides and plant growth regulator. The sensitivity assays of strains AD1–8-pYES2 and AD1–8:PDR1 with
propiconazole, iprodione, boscalid, flurprimidol, and paclobutrazol were reported in previous studies (19, 49).
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upstream region of ShPDR1 and the YFP chimeric construct, was exposed to propi-
conazole for 40 min. A deletion of the region between bp 1289 and 479 with
respect to the ATG initiation codon had no effect on either constitutive YFP gene
expression or propiconazole-induced YFP gene expression. Further deletion of the 5=
end of the promoter between bp 479 and 303 had a dramatic effect on the
constitutive and propiconazole-induced YFP gene expression. This observation sug-
gested the presence of a region containing an element participating in constitutive
overexpression of ShPDR1 due to ShXDR1 binding to this region and induced expres-
sion of ShPDR1 by the propiconazole treatment (Fig. 7A). Chromatin immunoprecipi-
tation (ChIP) experiments using hemagglutinin (HA) antibody directed against the
DNA-binding domain of ShXDR1 confirmed that this protein was indeed bound to
the promoter region of ShPDR1 between bp 448 and 342 in strain HRS10 (Fig. 7B).
The results from promoter deletion and ChIP analysis suggested the putative binding
motif between bp 373 and 354 (5= CGGCTGTTCAATAATACCG 3=) (underline indi-
cates trinucleotide sequences might be recognized by zinc cluster proteins) on the
promoter region of ShPDR1. Additional ChIP analysis indicated that ShXDR1 was also
bound to the promoter region of CYP561 between bp 493 and 387 (Fig. 7B), which
contains the putative binding motif between bp 436 and 418 (5= CGGATGTTACA
TTTACCG 3=). Using the MEME motif discovery tool, consensus inverted repeat se-
quences CGG(N12 or N13)CCG were found upstream of two other CYP450s and ShatrD,
implying that ShXDR1 is bound to the predicted DNA binding motif in the promoter
region of three CYP450s, ShPDR1, and ShatrD for the regulation of xenobiotic detoxi-
fication (see Fig. S4A in the supplemental material).
In addition to three CYP450 genes and two ABC transporter genes, four more genes
from group A (Fig. 1A) were confirmed to be regulated by ShXDR1. The genes are
involvedwith emopamil binding (TCONS_00010618), cellulose-binding family II (TCONS_
0003057), lysophospholipase (TCONS_00002727), and hypothetical protein (TCONS_
FIG 5 An activating mutation in a xenobiotic detoxification regulator 1 (ShXDR1) confers multidrug resistance by constitutive and induced overexpression of
phase I and III genes. (A) Schematic diagram of the ShXDR1 transcription factor showing an amino acid substitution (methionine to threonine) in the MDR strains
and alignment to the corresponding region of the mutation in sensitive (Sen) and MDR strains. (B) Sensitivity of strains HRS10, HRI11, HRI11(ΔShXDR1), and
HRI11(ShXDR1M853) to fungicides and plant growth regulator. (C) Relative expression (RE) of phase I genes (CYP561, CYP65, and CYP68) and phase III genes
(ShPDR1 and ShatrD) before and after exposure to propiconazole (1 g ml1) for 40 min in strains HRS10, HRI11, HRI11(ΔShXDR1), and HRI11(ShXDR1M853).
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00023546). A BLASTX search revealed that the hypothetical protein shares low homol-
ogy with 1-aminocyclopropane-1-carboxylate (ACC) deaminase from Streptomyces
rubellomurinus (accession no. WP_045693734) and were identified by an E value of 0.78
and coding sequence coverage of 47%. The query sequence shares 30% of amino acid
identity with ACC deaminase (32 out of 106). These four genes were constitutively
overexpressed and induced by propiconazole in the MDR strain HRI11, but had
decreased expression in the mutant HRI11(ΔShXDR1) and were overexpressed in
HRS10(ShXDR1T853) (Fig. S4B). The consensus inverted repeat sequences CGG(N11 or
N13)CCG was also found in the upstream region of these four genes using the MEME
motif discovery tool (Fig. S4A).
Conserved detoxification systems through transcriptional regulation of phase
I and III genes in filamentous fungi. To assess whether the xenobiotic detoxifica-
tion pathway is conserved in other filamentous ascomycete fungi, we introduced
ShXDR1T853 into a plant-pathogenic fungus, Botrytis cinerea. Two B. cinerea transfor-
mants containing ShXDR1T853 displayed increased resistance to propiconazole and
iprodione, but not to boscalid and flurprimidol (Fig. 8A). The wild-type B. cinerea strain
significantly induced expression of CYP450 enzyme gene BcCYP65 and ABC transporter
gene BcatrD in response to propiconazole. In the presence of ShXDR1T853, in B. cinerea,
the BcCYP65 and BcatrD genes were constitutively overexpressed and highly induced
by propiconazole compared to the wild-type strain (Fig. 8B). The foreign transcription
factor harboring the gain-of-function mutation confers the MDR phenotype in B. ci-
nerea through regulation of phase I and III genes, indicating that the xenobiotic
detoxification system is conserved in filamentous ascomycete fungi.
DISCUSSION
Our systematic analysis of MDR in S. homoeocarpa using RNA-seq and genetic
modification approaches has revealed key factors for xenobiotic detoxification. We
FIG 6 A mutation in a xenobiotic detoxification regulator 1 (ShXDR1) is a dominant gain-of-function mutation leading to multidrug resistance by constitutive
and induced overexpression of phase I and III genes. (A) Sensitivity of strains HRS10, HRI11, and HRS10(ShXDR1T853)-1 and -2 to fungicides and plant growth
regulator. (B) Relative expression (RE) of phase I and III genes before and after exposure to propiconazole (1 g ml1) for 40 min in strains HRS10, HRI11, and
HRS10(ShXDR1T853)-1 and -2.
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have elucidated the molecular mechanisms of xenobiotic detoxification for the first
time in fungi, which are through the coordinated transcriptional regulation of genes
coding for phase I metabolizing enzymes, CYP561, CYP65, and CYP68, and phase III
efflux transporters, ShPDR1 and ShatrD, under the control of a fungus-specific tran-
scription factor, ShXDR1. In addition, a gain-of-function mutation in ShXDR1 causes
constitutive and drug-induced overexpression of phase I and III genes, contributing to
MDR in the S. homoeocarpa field strain.
RNA-seq analysis of drug-sensitive and MDR strains indicated that constitutively
overexpressed genes in the MDR strain were typically associated with xenobiotic
detoxification (Fig. 1C; see Fig. S5A in the supplemental material). However, many of
the constitutively overexpressed genes in the MDR strain were not induced by propi-
conazole, and only 13 transcripts (group A) including three CYPs and two ABC trans-
porters, showed the propiconazole-induced expression pattern. These phase I and III
genes were rapidly and transiently activated in response to structurally different
chemicals. Overexpression of CYP561, CYP65, and CYP68 conferred resistance to propi-
conazole and flurprimidol and displayed various insensitivities to boscalid and iprodi-
one, which might be due to the different substrate specificity of CYPs. A BLAST search
in the Fungal Cytochrome P450 Database (FCPD: http://p450.riceblast.snu.ac.kr) and
phylogenetic analysis revealed that the products of CYP561 and CYP65 belong to clan
CYP65 and the product of CYP68 belongs to clan CYP68 (see Fig. S6A in the supple-
mental material). The functional classification of clans CYP65 and CYP68 was deter-
mined as secondary metabolism (for example, mycotoxin trichothecene biosynthesis by
CYP65 and gibberellin biosynthesis by CYP68) (25, 26), but our findings suggest
additional functions of clans CYP65 and CYP68 in xenobiotic metabolism. Screening of
phase II enzymes from RNA-seq data revealed only one phase II glutathione
S-transferase (TCONS_00005783) was highly overexpressed in the MDR strain, but the
FIG 7 Detection of xenobiotic-responsive element (XRE) and interaction between ShXDR1 and the promoter region of the ShXDR1
target gene regulon. (A) Promoter deletion analysis of pShPDR1-YFP chimeric constructs. The promoter 5= deletions in ShPDR1 are
schematized with their corresponding plasmid constructs and S. homoeocarpa mutants. Relative expression (RE) of YFP is given for
each mutant before and after exposure to propiconazole. The black region in 479 bp upstream of ShPDR1 indicates the potential
promoter region containing the ShXDR1 binding motif. (B) Chromatin immunoprecipitation (ChIP) analysis of HA-tagged fusion
ShXDR1 occupancy on promoters of ShPDR1 (448 bp to 342 bp) and CYP561 (493 bp to 387 bp) in the absence and presence
of propiconazole. The presence of the promoter region of ShPDR1, CYP561, or Shact (as a negative control) sequence was assayed by
quantitative PCR. The y axis depicts the fold enrichment over a mock immunoprecipitation control that lacks HA antibody. HRS10HA-P
indicates HA-expressing strain HRS10 treated with propiconazole (1 g ml1).
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gene was not an ShXDR1 target gene regulon, and overexpression of the gene did not
affect the biotransformation rate of propiconazole (Fig. S5B and C).
Mutants with the ABC transporter overexpressed exhibited broad-spectrum resis-
tance to chemicals. Interestingly, ShPDR1 conferred resistance to higher concentrations
of chemicals compared to ShatrD in the heterologous expression system in yeast. In a
mutagenesis study of ABC transporter Cdr1 transmembrane domains (TMDs) in C. al-
bicans, only five mutations in transmembrane segments (TMSs) lead to reduced efflux
and ATPase activity of Cdr1 (27). Three amino acids (F559, E564, and G672) in Cdr1 are
conserved in Cdr2 from C. albicans and ShPDR1 and ShatrD, but one of the amino acids
(T677) in TMS5 of Cdr1 matches with T693 in ShPDR1, but not Cdr2 and ShatrD
(Fig. S6C). This amino acid difference might contribute to decreased efflux activity of
Cdr2 or ShatrD to a variety of chemicals and a high concentration (28) because these
4 amino acids are associated with the open and closed conformations of the TMDs,
affecting ATP hydrolysis by the nuclear binding domains (NBDs) (27). The phenotypes
of S. homoeocarpa and S. cerevisiae mutants with ShPDR1 and ShatrD overexpressed in
response to propiconazole also suggest that these transporters are involved in two
steps (phase 0 and phase III) of disposal for parent xenobiotics and biotransformed
xenobiotics, respectively, since propiconazole was biotransformed in S. homoeocarpa
and not in S. cerevisiae (Fig. S6D). Our results propose that the activities of phase I genes
FIG 8 Conserved detoxification systems through transcriptional regulation of phase I and III genes in
Botrytis cinerea. (A) Sensitivity of Botrytis cinerea strains BC-001 and BC-001(ShXDR1T853)-1 and -2 to
fungicides and plant growth regulator. (B) Relative expression (RE) of phase I gene BcCYP65 and phase
III gene BcatrD before and after exposure to propiconazole (1 g ml1) for 40 min in strains BC-001 and
BC-001(ShXDR1T853)-1 and -2.
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CYP561, CYP65, and CYP68 contribute to catalyzing xenobiotics with different substrate
specificities, and phase III genes ShPDR1 and ShatrD are involved in excretion of
xenobiotics or their metabolites.
We found the xenobiotic detoxification regulator ShXDR1 has two highly conserved
domains in comparison with Pdr1 from S. cerevisiae and Tac1 from C. albicans (see
Fig. S7A in the supplemental material). The first conserved domain is a cysteine-rich
motif at the N terminus, involved in zinc-dependent binding to DNA, and the other
domain is a part of xenobiotic binding domain (XDB) in the middle of the protein (3).
The ChIP and promoter deletion analysis suggests that this DNA binding domain (DBD)
of ShXDR1 constitutively binds to the upstream region of ShPDR1 and CYP561, and
likely others, and possibly binds as a homodimer to its DNA binding motif, CGG(N12–
13)CCG. The presence of the XDB suggests that activated ShXDR1 may initiate tran-
scriptional expression of phase I and III genes through direct binding of xenobiotics. In
addition to xenobiotic binding, the substrates of ShXDR1 could be endobiotics because
CYP65, CYP68, ShPDR1, and ShatrDwere constitutively overexpressed without treatment
with any chemicals in the HRS10 mutant with CYP561 overexpressed (see Fig. S8 in the
supplemental material). Phylogenetic analysis and MDR phenotypes of the B. cinerea
strain caused by ShXDR1T853 expression reveal that ShXDR1 orthologs are conserved in
genomes of filamentous ascomycete fungi capable of xenobiotic detoxification (Fig. 8;
Fig. S7B). Thakur et al. provided evidence of mechanistic similarities for MDR regulation
between fungal zinc cluster Pdr1 orthologs and the mammalian PXR nuclear receptor
(3), but Pdr1 orthologs do not regulate the expression of phase I enzymes, which are
a main factor of PXR regulation for xenobiotic detoxification. This absence of phase I
regulation in Pdr1 might be attributed to extensive CYP450 gene loss in ascomycete
yeasts (29), and this fungal group contains small CYP-omes lacking some globally or
locally conserved CYP families, including clans CYP65 and CYP68 (25, 29), whereas,
filamentous ascomycete fungi, including S. homoeocarpa, comprise the large number of
members of the CYP family/subfamilies (29, 30). The coordinated regulation of CYPs
and ABC transporters by ShXDR1 indicates that the fungal transcription factor is
mechanistically analogous to PXR, which regulates CYP450s (especially CYP3A), and the
P-glycoprotein family of ABC transporters (31, 32). Intriguingly, the fungal CYP561
family in clan CYP65 is phylogenetically close to two human CYP3A43 proteins iden-
tified as belonging to the CYP561 family, and both groups of proteins share the amino
acid sequences in conserved protein domain family CypX (COG2124) (Fig. S6B). In
addition, both S. homoeocarpa CYPs and human CYP3A enzymes have the ability to
detoxify propiconazole (20), and upregulation of CYPs and ABC transporters by
ShXDR1/PXR is a main factor for multidrug resistance in S. homoeocarpa and human
cancer (9, 33, 34). This evidence proposes that the set of three components—CYPs, ABC
transporters, and ShXDR1/PXR—is a key factor for xenobiotic detoxification in eu-
karyotes. Importantly, these evolutionarily parallel fungal and mammalian CYPs and
ABC transporters regulated by the structurally unrelated transcription factors ShXDR1
and PXR, suggesting the detoxification system in eukaryotes has evolved convergently.
In this study, we determined a dominant gain-of-function mutation (M853T) in the
activation domain of ShXDR1 renders constitutive overexpression of phase I and III
genes responsible for multidrug resistance. C. albicans azole-resistant strains also
contain a gain-of-function mutation in the activation domain of Tac1 (N972D, N997D,
and G980E) that confers constitutive upregulation of the ABC transporter genes CDR1
and CDR2, resulting in increased antifungal resistance (10, 12, 35). In addition, an
activation mutation (F815S) in Pdr1 of S. cerevisiae enhances occupancy of coactivator
complexes at the ABC transporter PDR5 promoter accompanied by loss of contacts
between histones and DNA, and it also alters chromatin structure at both promoter and
coding sequences of PDR5 (36). Since the mutation in ShXDR1 occurs in the C-terminal
region that harbors the transcriptional activation domain, the mutation might affect the
interaction between ShXDR1 and a coactivator or repressor. The activation domain of
S. cerevisiae Pdr1 interacts with the KIX domain of the gal11 mediator coactivator, which
recruits RNA polymerase II for transcription of ABC transporters (3). We identified a
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putative coactivator, gal11 (TCONS_00010521), containing a gal11 coactivator domain
(accession no. cd12191), but gal11 was not a coactivator of ShXDR1, which was
confirmed by gal11 deletion mutants in the MDR strain. Further studies will mine the
candidate coactivators that potentially interact with ShXDR1 and compare the inter-
action of the coactivator between ShXDR1M853 and ShXDR1T853.
Additional parts of the ShXDR1 regulon are four genes encoding enopamil binding,
phospholipase B1, cellulose-binding family II, and a hypothetical protein. Emopamil
binding proteins (EBPs) are integral membrane proteins of the endoplasmic reticulum
and bind sigma ligands and structurally diverse drugs and fungicides on the emopamil
binding domain (EBD) (37). The protein may contribute to phase III of the xenobiotic
detoxification system because EBPs share similar structural features with drug trans-
porters, especially due to a high content of aromatic amino acid residues in transmem-
brane segments (38), which have been suggested to be involved in the drug transport
by the P-glycoprotein (39). In addition, both phospholipase B1 (Plb1) and cellulose-
binding family II are enzymes involved in hydrolysis of glycerophospholipids and
cellulose, respectively (40, 41). Although the phase I reaction may occur by hydrolysis,
the involvement of Plb1 and cellulose-binding family II in xenobiotic detoxification is
unknown.
Our first establishment of a xenobiotic detoxification mechanism through metabo-
lizing enzymes and efflux transporters coordinately regulated by a transcription factor
in fungi may aid in the discovery of new target genes for fungicides to control MDR
populations in plant and human filamentous pathogenic fungi. For example, the
detailed molecular knowledge of the MDR mechanisms in C. glabrata facilitated the
discovery of a small-molecule compound, iKIX1, that inhibits the interaction of the Pdr1
activation domain with the Gal11A KIX domain for resensitizing drug-resistant
C. glabrata to azole antifungals (3, 13). Furthermore, the results describing a mutation
in the regulator from this study will be used to understand a protein conformational
flexibility to posit an explanation for ShXDR1 substrate promiscuity. Also, development
of a detection tool for fungicide resistance populations will be helpful for better
management of dollar spot on golf courses. The mechanistic similarities of ShXDR1 and
PXR regulation provide the impetus for further exploration of PXR-mediated MDR in
human cancer using the fungal system and further studies of convergent and divergent
evolution of xenobiotic detoxification in eukaryotes.
MATERIALS AND METHODS
Fungal strains. Fungal strains used in this study are presented in Table 1. Ten strains of S. homoeo-
carpa used in this study were collected from Hickory Ridge Golf club (Amherst, MA) and were previously
characterized in field efficacy, fungicide sensitivity, and fungicide resistance molecular mechanism
studies (19, 20, 42). Strains HRS10 and HRI11 were sampled prior to treatment of a demethylation
inhibitor fungicide (propiconazole). Strains HRS1 to HRS4 were sampled from plots that received no
fungicide treatment, and HRI1 to HRI4 were sampled 7 days after treatment. (Strains HRI1 to -4 were
considered to demonstrate “practical field resistance.”) HRS10 and HRS1 to HRS4 were considered
fungicide-sensitive strains based on a previous in vitro fungicide sensitivity assay. HRI11 and HRI1 to HRI4
are considered multidrug-resistant (MDR) strains and exhibited reduced sensitivities to propiconazole,
iprodione, and boscalid (19).
RNA sequencing and transcript abundance. An Illumina Hiseq 2000 was used to sequence two
biological replicates under each condition, yielding over 75 million Hiseq 2000 reads for every condition.
Hisat2 version 2.0.4 was used to create the alignment files onto the genome of HRI11 (accession no.
LNKV00000000). Predicted transcripts of the recently sequenced Sclerotinia homoeocarpa genomes (22)
were used to guide transcript assembly by Cufflinks using the –g flag. Transcript abundance was
estimated by fragments per kilobase of transcript per million fragments of mapped reads (FPKM). A total
of 12,008 genes were identified from the 28,914 transcripts. Significantly expressed genes were identified
by log2 fold change greater than 1.5 and a P value below 0.05. Transcripts with FPKM below a 0.05
threshold were discarded in the differential expression analysis. Cluster analysis and heat map generation
were conducted with the Genesis software (version 1.7.7) based on the hierarchical and complete linkage
clustering method (http://genome.tugraz.at) (43). For functional annotation, the Blast2GO analysis was
performed at https://www.blast2go.com. The predicted S. homoeocarpa coding sequences were
searched for identical sequences by conducting BLASTX search. A cutoff E value of 1010 was used for
BLASTX and annotation.
Plasmid construction and generation of S. homoeocarpa and B. cinerea mutants. For overex-
pression of phase I genes (CYP561, CYP65, and CYP68) and phase III genes (ShPDR1 and ShatrD), plasmid
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pYHN3-ptrpC was constructed by cutting pShEF1 and inserting ptrpC in plasmid pYHN3-pShEF1 (44).
The full length of five genes amplified from genomic DNA (gDNA) of HRI11 was inserted into plasmid
pYHN3-ptrpC to generate the plasmids pYHN3-ptrpC-CYP561, -CYP65, -CYP68, -ShPDR1, and -ShatrD,
respectively. Each plasmid DNA (5 g) was used for a polyethylene glycol (PEG)-mediated transformation
in protoplasts from HRS10. The protoplast generation and PEG-mediated transformation were conducted
according to Sang et al. (44). Phase I and III overexpression mutants HRS10(CYP561OX), HRS10(CYP65OX),
HRS10(CYP68OX), HRS10(ShPDR1OX), and HRS10(ShatrDOX) were confirmed by quantitative PCR (qPCR)
analysis, and the genes in those mutants were expressed 2,190-, 277-, 97,024-, 68-, and 13-fold more than
in HRS10, respectively.
The transcription factor (TF) ShXDR1T853 containing mutation M853T is from MDR strain HRI11, and
the wild-type TF, ShXDR1M853, is from HRS10. The HRI11 ShXDR1 deletion and ShXDR1M853 mutants were
generated using the split marker approach and PEG-mediated protoplast transformation as described
earlier (44). For deletion of ShXDR1, a 1-kb upstream region and downstream region of the ShXDR1
amplified from genomic DNA of HRI11 were inserted into between the hygromycin resistance cassette
(PtrpC-hph) in the plasmid Topo-hph (44) to generate the plasmid Topo-ΔShXDR1. Two constructs (one
with 1 kb of upstream region of the ShXDR1 and 731 bp of hph and one with 1 kb of downstream region
of the ShXDR1 and 1,126 bp of PtrpC-hph) were amplified from plasmid Topo-ΔShXDR1. For ShXDR1M853
mutants, Topo-ShXDR1M853 was constructed by cutting the upstream region of ShXDR1 in Topo-
ΔShXDR1 and inserting the partial region of ShXDR1M853 from HRS10. Two constructs (one with the
partial region of the ShXDR1 and 731 bp of hph and one with 1 kb of downstream region of the ShXDR1
and 1,126 bp of PtrpC-hph) were amplified from plasmid Topo-ShXDR1M853. The purified two constructs
(each 2 g) were used for the PEG-mediated transformation in protoplasts from HRI11. Mutants
HRI11(ΔShXDR1) and HRI11(ShXDR1M853) were confirmed by PCR amplification with four primer pairs
according to the method described by Sang et al. (44). ShXDR1M853 in mutant HRI11(ShXDR1M853) was
sequenced to confirm the replacement. For the complementation of the mutants, the plasmid NeoR-
ShXDR1T853 containing the neomycin resistance gene and upstream region (1,581 bp) and the full length
of ShXDR1T853 was transformed into protoplasts of HRI11(ΔShXDR1) and HRI11(ShXDR1M853), respec-
tively. Complemented mutants gained resistance to propiconazole and validated the phenotypes of the
mutants HRI11(ΔShXDR1) and HRI11(ShXDR1M853). For ShXDR1 mutants from HRS10 and B. cinerea strain
BC-001, the 1,581 bp of upstream region and full length of ShXDR1T853 amplified from gDNA of HRI11
were inserted into plasmid pYHN3-MCS (44) to generate plasmid pYHN3-ShXDR1T853. The plasmid DNA
(5 g) was used for the PEG-mediated transformation in protoplasts from HRS10 and BC-001. The
presence of ShXDR1T853 transcript in BC-001(ShXDR1T853) mutants was confirmed by qPCR analysis.
pShPDR1-YFP chimeric mutants were generated for promoter deletion analysis. Different lengths
(303, 354, 479, and 1,289 bp) of ShPDR1 promoter were amplified from gDNA of HRI11 and inserted
into plasmid pYHN3 (24) to generate pYHN3-303bp-pShPDR1, pYHN3-354bp-pShPDR1, pYHN3-
479bp-pShPDR1, and pYHN3-1289bp-pShPDR1. Five micrograms of each plasmid was transformed
TABLE 1 Fungal strains used in this study
Strain Description Source
HRS10 S. homoeocarpa drug-sensitive strain Sang et al. (19)
HRI11 S. homoeocarpa MDR strain Sang et al. (19)
HRS1 to -4 S. homoeocarpa drug-sensitive strains Sang et al. (19)
HRI1 to -4 S. homoeocarpa practical field resistance strains Sang et al. (19)
HRS10(CYP561OX) HRS10 mutant with CYP561 overexpressed This study
HRS10(CYP65OX) HRS10 mutant with CYP65 overexpressed This study
HRS10(CYP68OX) HRS10 mutant with CY68 overexpressed This study
HRS10(ShPDR1OX) HRS10 mutant with ShPDR1 overexpressed This study
HRS10(ShatrDOX) HRS10 mutant with ShatrD overexpressed This study
HRS10(ShXDRT853)-1 and -2 HRS10 mutants with ShXDR1T853 expressed This study
HRI11(ΔShXDR1) HRI11 ShXDR1 knockout mutant This study
HRI11(ΔShXDR1  ShXDR1T853)-1 and -2 HRI11(ΔShXDR1) complemented mutants This study
HRI11(ShXDR1M853) HRI11 mutant with ShXDR1M853 expressed This study
HRI11(ShXDR1M853  ShXDR1T853)-1 and -2 HRI11(ShXDR1M853) complemented mutants This study
HRI11(303bp-pShPDR1) HRI11 mutant with 303-bp upstream region of ShPDR1-YFP chimeric construct This study
HRI11(354bp-pShPDR1) HRI11 mutant with 354-bp upstream region of ShPDR1-YFP chimeric construct This study
HRI11(479bp-pShPDR1) HRI11 mutant with 479-bp upstream region of ShPDR1-YFP chimeric construct This study
HRI11(1289bp-pShPDR1) HRI11 mutant with 1,289-bp upstream region of ShPDR1-YFP chimeric construct This study
HRI11(dsRNA-ShXDR1)-1 and -2 HRI11 ShXDR1 knockdown mutants This study
HRS10HA HRS10 mutant with HA-tagged ShXDR1 This study
HRS10(TNCOS_00005783) HRS10 mutant with glutathione S-transferase overexpressed This study
BC-001 Botrytis cinerea strain This study
BC-001(ShXDR1T853)-1 and -2 BC-001 mutants with ShXDR1 expressed This study
AD12345678 (AD1–8) Saccharomyces cerevisiae drug-hypersensitive mutant Decottignies et al.a
AD1–8-pYES2 AD1–8 mutant with empty pYES2 vector Sang et al. (19)
AD1–8:PDR-1 and -2 AD1–8 mutant with ShPDR1 overexpressed Sang et al. (19)
AD1–8:atrD-1 and -2 AD1–8 mutant with ShatrD overexpressed This study
aSee Text S1 in the supplemental material.
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into protoplasts from HRI11. In addition, the HA-tagged fusion ShXDR1 mutant was generated for
chromatin immunoprecipitation. The full length of ShXDR1M853 without a stop codon (TAA) from
gDNA of HRS10 was fused with HA tag from plasmid pPAD80 (45) by two rounds of PCR. The
HA-tagged fusion ShXDR1 was inserted into plasmid pYHN3-ptrpC to generate plasmid pYHN3-
ptrpC-ShXDR1HA. This plasmid (5 g) was used for PEG-mediated transformation in protoplasts from
HRS10. The presence and overexpression of ShXDR1HA transcript in HRS10HA mutant were con-
firmed by qPCR analysis.
HPLC analysis. Potato dextrose broth (PDB; 50 ml) with and without mycelia (approximately 1 g)
from strain HRS10 and mutants with CYP561, CYP65, and CYP68 overexpressed was supplemented with
propiconazole (1 g ml1) and cultured at 25°C (100 rpm). The sample from extracellular growth medium
was prepared at each time point (0, 6, 12, 24, 48, and 72 h) by a methanol extraction method (46). An
Agilent 1200 Series high-performance liquid chromatography (HPLC) equipped with a diode array
detector (DAD) was used for the detection and quantification of propiconazole. Separation was per-
formed on an Agilent Eclipse XDB C18 column (4.6 by 150 mm, 5 m) using a 12-min linear gradient of
acetonitrile in water (50 to 90%) at a flow rate of 1.5 ml min1. The DAD was set at 220 nm and the UV
spectra from 190 to 400 nm were recorded for detection of transformation products.
Quantitative real-time RT-PCR. Total RNA of S. homoeocarpa was extracted using the methods
detailed by Sang et al. (19). cDNA synthesis from total RNA was conducted with the QuantiTect reverse
transcription kit (Qiagen, USA). The cDNA was used at an 8-fold dilution, and 1 l was used for real-time
quantitative PCR with Maxima SYBR green (Thermo Fisher Scientific, USA). The S. homoeocarpa actin gene
(Shact) was selected as a housekeeping gene, and the primers for ShatrD, ShPDR1, and Shact were
described by Hulvey et al. (20) and Sang et al. (19). Other primers used in qPCR were described in
Table S1 in the supplemental material. The comparative threshold cycle (CT) method was used for
calculation of relative gene expression (47).
Chemical sensitivity assays. In vitro sensitivity assays were conducted on the S. homoeocarpa strains
with different classes of fungicides and plant growth regulator. Flurprimidol EC50 values for all 10 field
strains were obtained using the method from Sang et al. (19). The concentrations of flurprimidol used for
measuring the EC50 were 0.1, 1, 10, 100, and 1,000 g ml1. The propiconazole and iprodione EC50 values
and boscalid EC95 values from 10 field strains previously used by Sang et al. (19) were reanalyzed in the
present study. For in vitro sensitivity tests of S. homoeocarpa mutants and the control strains (HRS10 and
HRI11), all strains were grown for 3 days at room temperature, and agar plugs (5 mm in diameter) were
extracted from active colonies and inoculated onto the center of nonamended potato-dextrose agar
(PDA) plates and each of the chemical-amended PDA plates. After 2 to 5 days, pictures of plates were
taken (10 days for HRS10 mutants with ShPDR1 and ShatrD overexpressed on PDA amended with
flurprimidol), and two diameters of the colony were measured using 16EX digital calipers (Mahr,
Göttingen, Germany). The relative mycelium growth (RMG) percentages of strains were calculated. The
experiment was repeated three times.
Chromatin immunoprecipitation. The procedure for chromatin immunoprecipitation was modified
from Boedi et al. (48). Briefly, S. homoeocarpa mycelia grown in PDB (Becton, Dickinson, USA) for 4 days
were not treated or were treated with 1 g/ml of propiconazole for 40 min. The mycelia were fixed with
1% of formaldehyde for 15 min and incubated with glycine (125 mM) for 5 min using a shaker at 50 rpm.
The mycelia were recovered by filtration, rinsed twice with 20 ml phosphate-buffered saline (PBS), and
frozen in liquid nitrogen. The mycelia were ground to fine power with a mortar and pestle in liquid
nitrogen, and 100 mg of ground mycelia was suspended in 1.5 ml of nucleus lysis buffer (50 mM
HEPES-KOH, pH 7.5, 140 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% sodium deoxycholate, 1 mM
phenylmethylsulfonyl fluoride [PMSF], with 1 protease inhibitor from Sigma). After the sample was
centrifuged at 12,000  g at 4°C for 10 min, the chromatin (supernatant) was transferred to a new tube.
The chromatin was subjected to sonication for 25 s 12 times at power setting 35% with a Sonics VibraCell
sonicator (Sonics & Materials, USA) and clarified by centrifugation at 12,000  g at 4°C for 5 min. Six
hundred microliters of chromatin was incubated with prewashed protein A magnetic beads (Thermo
Scientific, USA) at 4°C for 1 h, and chromatin was separated from the beads using a magnetic stand.
Prewashed anti-HA magnetic beads (Thermo Scientific, United States) were added to chromatin, and the
mixture was incubated at 4°C overnight for immunoprecipitation. The bead-bound material was recov-
ered using a magnetic stand, washed twice in 1 ml of low-salt washing buffer (20 mM Tris-HCl, pH 8.0,
150 mM NaCl, 2 mM EDTA, 0.5% Triton X-100, 0.1% SDS), twice in 1 ml of high-salt washing buffer (20 mM
Tris-HCl, pH 8.0, 500 mM NaCl, 2 mM EDTA, 0.5% Triton X-100, 0.1% SDS), twice in 1 ml of LiCl washing
buffer (10 mM Tris-HCl, pH 8.0, 0.5% NP-40, 1 mM EDTA, 0.5% sodium deoxycholate, 0.25 M LiCl·H2O), and
twice in 1 ml of Tris-EDTA (TE: 10 mM Tris-HCl, pH 8.0, 1 mM EDTA). Beads were then resuspended in
elution buffer (1% SDS, 0.1 M NaHCO3) and incubated with NaCl (5 M) at 65°C overnight to reverse
cross-links. After the cross-links were reversed, 0.5 M EDTA, 1 M Tris-HCl (pH 6.5), and 10 mg ml1
proteinase K were added to the sample, and the mixture was incubated at 45°C for 1 h. DNA from the
sample was extracted with chloroform, precipitated with ethanol, 0.3 M sodium acetate (pH 5.2), and 1 l
glycogen (20 mg/ml), and resuspended in 50 l double-distilled H2O (ddH2O). The purified DNA was
analyzed by qPCR.
Statistical significance tests. All statistical analyses were performed with the JMP software package,
version 10.0 (SAS Institute, Inc.).
Accession number(s). Reads generated in this study have been deposited in the National Center for
Biotechnology Information Sequence Read Archive under accession no. SRP116271.
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